More Company News

Scancell

SCIB1 IND application approved
03 Feb 2020Read More

Scancell

H120 interim results
31 Jan 2020Read More

Scancell

Third agreement signed for antibody platform
20 Jan 2020Read More

Scancell

Second agreement signed for AvidiMab platform
16 Dec 2019Read More

Scancell

New European Moditope patent allowed for grant
20 Nov 2019Read More

Scancell

Six posters at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
26 Sep 2019Read More

Scancell

First collaboration agreement for its new platform technology, AvidiMab
04 Sep 2019Read More

Scancell

FY19 preliminary results
20 Aug 2019Read More

Scancell

SCIB1 study update
19 Aug 2019Read More

Scancell

H1 2019 business update
01 Jul 2019Read More

1 2 3
Return to Scancell
© 2019-20 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).